| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Biomedical Sciences, Cornell University, Ithaca, NY.
Correspondence to Robert F. Gilmour, Jr, Department of Biomedical Sciences, T7 012 VRT, Cornell University, Ithaca, NY 14853-6401. E-mail rfg2{at}cornell.edu
Previous modeling studies have suggested that the rapid component of the delayed rectifier (IKr) may contribute importantly to action potential dynamics during tachycardia. To test this idea experimentally, IKr was measured as the E-4031sensitive current in isolated canine endocardial myocytes at 37°C using the perforated patch-clamp technique. Command potentials were trains of action potential waveforms recorded at cycle lengths (CLs) of 1000, 500, 320, 170, and 120 ms. Action potential duration (APD) alternans occurred at CLs of 170 and 120 ms. During an action potential, IKr increased gradually to a maximum at 55 to 60 mV. Peak IKr increased initially as CL was shortened from 1000 to 500 ms (from 0.55±0.03 to 0.57±0.03 pA/pF), but decreased progressively as CL was shortened further (to 0.45±0.03 pA/pF at CL=120 ms). Baseline IKr was negligible at CLs of 1000 to 320 ms, but increased to 0.12±0.01 pA/pF at a CL of 120 ms. During APD alternans, peak IKr was larger for the short than for the long action potential (0.48±0.03 versus 0.46±0.03 pA/pF). A computer model of IKr based on these data indicated that increasing IKr suppressed alternans and decreasing IKr increased alternans. In support of the latter result, inhibition of IKr by E-4031 increased the maximal amplitude of alternans. These results indicate that IKr contributes importantly to rate-related alterations of repolarization, including APD alternans. Modifying IKr may be a promising approach to suppressing alternans and thereby preventing ventricular tachyarrhythmias.
Key Words: IKr alternans ventricular arrhythmias
This article has been cited by other articles:
![]() |
M. Perry, F. B. Sachse, and M. C. Sanguinetti Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator PNAS, August 21, 2007; 104(34): 13827 - 13832. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Livshitz and Y. Rudy Regulation of Ca2+ and electrical alternans in cardiac myocytes: role of CAMKII and repolarizing currents Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2854 - H2866. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Suto, W. Zhu, A. Chan, and G. J. Gross IKr and IKs remodeling differentially affects QT interval prolongation and dynamic adaptation to heart rate acceleration in bradycardic rabbits Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1782 - H1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamazaki, H. Honjo, H. Nakagawa, Y. S. Ishiguro, Y. Okuno, M. Amino, I. Sakuma, K. Kamiya, and I. Kodama Mechanisms of destabilization and early termination of spiral wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H539 - H548. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Casis, S.-P. Olesen, and M. C. Sanguinetti Mechanism of Action of a Novel Human ether-a-go-go-Related Gene Channel Activator Mol. Pharmacol., February 1, 2006; 69(2): 658 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Koller, S. K.G. Maier, A. R. Gelzer, W. R. Bauer, M. Meesmann, and R. F. Gilmour Jr Altered Dynamics of Action Potential Restitution and Alternans in Humans With Structural Heart Disease Circulation, September 13, 2005; 112(11): 1542 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Royer, S. Demolombe, A. El Harchi, K. Le Quang, J. Piron, G. Toumaniantz, D. Mazurais, C. Bellocq, G. Lande, C. Terrenoire, et al. Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity Cardiovasc Res, January 1, 2005; 65(1): 128 - 137. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |